Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
The great people I work with.
Quali sono alcune delle cose migliori della tuo team?
Most friendly welcoming team that I have worked with!
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
Such a warm welcoming environment!
Cosa ti piace di più del team di leadership?
Very teamwork oriented. The team strives to accomplish goals and milestones to better the company.
Other Employee Reviews for Karyopharm Therapeutics
×